Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87.0Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M87.0EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M6,200,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DGZ

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

DGZ is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DGZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.99605.03view
Dubuc, PhilippeSenior Officer 2016-04-08Buy3,300$2601.5view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-04-08Buy10,000$0.159253.33view
Williams, Allan WilliamSenior Officer 2016-04-08Buy108,500$0.1112654.55view
Stefura, Naomi MarieSenior Officer 2016-04-08Sell4,200$14.6-3.9view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell800$20.78-32.48view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell400$20.77-32.45view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell300$20.75-32.39view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell100$20.72-32.29view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell900$20.7-32.22view

Quarterly/Annual Reports about DGZ:

    News about DGZ:

    Articles On GuruFocus.com
    Sony's Focus On High Growth Areas Makes Me Bullish On the Stock Nov 25 2014 
    Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
    Citizens Bank Begins Ex-Dividend Trading Nov 04 2014 

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)